ZOE Science & NutritionShould you take Ozempic? The 5 things you need to know before starting GLP-1 drugs | Dr Ania Jastreboff

94% diabetes risk reduction

22:43–24:06 · 83s

Anya shares a three-year tirzepatide study in prediabetes showing a 94% reduction in progression to type 2 diabetes—but the benefits depended on continuing the medication.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.